SPDR S&P Biotech ETF Rating → Gold Mania (From Stansberry Research) (Ad) Free XBI Stock Alerts $89.98 +1.64 (+1.86%) (As of 05/3/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings SPDR S&P Biotech ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XBI Aggregate RatingModerate Buy2.74Holdings in XBI have an aggregate rating of Moderate Buy based on 581 analyst ratings issued in the past year covering 50 companies (54.1% of the portfolio).XBI Aggregate Price Target$117.4830.56% UpsideHigh Prediction$154.90Average Prediction$117.48Low Prediction$80.61Holdings in XBI have an aggregate price target of $117.48 and a range of $80.61 to $154.90 covering 50 companies (54.1% of the portfolio).XBI Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Biotech ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 XBI Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings1.88%ALPNAlpine Immune Sciences$64.602 of 5 stars2.27$50.33 -22.1%11Upcoming Earnings1.32%RVMDRevolution Medicines$40.20+2.6%3 of 5 stars3.10$41.20 2.5%10Upcoming EarningsInsider SellingGap Up1.30%IBRXImmunityBio$9.15+2.0%0 of 5 stars2.00$6.00 -34.4%1Upcoming EarningsGap Up1.26%VKTXViking Therapeutics$76.97+1.6%4 of 5 stars3.00$112.25 45.8%10Insider Selling1.22%MRNAModerna$125.00-0.5%3 of 5 stars2.25$129.55 3.6%16Earnings ReportAnalyst ReportInsider SellingAnalyst RevisionNews Coverage1.20%EXELExelixis$21.90-1.0%5 of 5 stars2.63$26.33 20.2%16Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage1.19%NTRANatera$96.98+3.5%2 of 5 stars3.00$86.40 -10.9%14Upcoming EarningsAnalyst UpgradeInsider SellingNews CoverageGap Up1.18%GERNGeron$3.93-0.5%4 of 5 stars2.80$6.10 55.2%5Analyst DowngradeShort Interest ↑Analyst RevisionNews CoverageGap Down1.18%CRNXCrinetics Pharmaceuticals$47.20+0.9%3 of 5 stars2.91$54.00 14.4%11Upcoming EarningsShort Interest ↑News Coverage1.18%CERECerevel Therapeutics$42.55-0.1%0 of 5 stars2.11$42.67 0.3%9Upcoming Earnings1.17%PTCTPTC Therapeutics$33.01-1.8%2 of 5 stars1.92$33.67 2.0%13Gap Up1.16%ROIVRoivant Sciences$11.39+1.3%4 of 5 stars2.90$16.90 48.4%10Positive NewsGap Up1.16%SRPTSarepta Therapeutics$133.66+2.3%4 of 5 stars2.79$160.60 20.2%14Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage1.14%AMGNAmgen$311.29+11.8%5 of 5 stars2.52$305.05 -2.0%21Earnings ReportAnalyst UpgradeInsider SellingAnalyst RevisionNews CoverageGap UpHigh Trading Volume1.13%BPMCBlueprint Medicines$107.19+0.2%1 of 5 stars2.47$94.87 -11.5%15Analyst ReportAnalyst RevisionNews CoverageGap Up1.12%NBIXNeurocrine Biosciences$140.71+0.6%5 of 5 stars2.74$147.88 5.1%23Analyst ReportAnalyst RevisionNews Coverage1.12%EXASExact Sciences$62.07+2.5%4 of 5 stars2.86$97.44 57.0%13Upcoming EarningsNews CoverageGap Up1.10%UTHRUnited Therapeutics$262.40+1.7%5 of 5 stars2.90$308.78 17.7%10Earnings ReportAnalyst ReportInsider SellingNews Coverage1.09%ALNYAlnylam Pharmaceuticals$152.33+1.3%5 of 5 stars2.59$215.88 41.7%17Earnings ReportAnalyst ReportNews CoverageGap Up1.09%BIIBBiogen$217.51+1.9%5 of 5 stars2.65$290.92 33.8%26Analyst Report1.08%DYNDyne Therapeutics$26.08+0.3%4 of 5 stars3.13$37.75 44.7%8Analyst ReportNews Coverage1.08%VRTXVertex Pharmaceuticals$401.08+0.2%4 of 5 stars2.48$430.86 7.4%23Upcoming EarningsAnalyst Upgrade1.08%RYTMRhythm Pharmaceuticals$43.76+6.8%1 of 5 stars3.00$47.20 7.9%5Upcoming Earnings1.07%BMRNBioMarin Pharmaceutical$82.44-1.6%5 of 5 stars2.63$107.50 30.4%191.07%IONSIonis Pharmaceuticals$41.97-2.6%4 of 5 stars2.69$57.67 37.4%13Upcoming EarningsPositive News1.06%CYTKCytokinetics$65.27+1.4%4 of 5 stars2.87$79.33 21.5%15Upcoming EarningsShort Interest ↑Gap Up1.05%REGNRegeneron Pharmaceuticals$957.00+2.1%4 of 5 stars2.70$977.77 2.2%20Analyst DowngradeInsider SellingNews Coverage1.04%SWTXSpringWorks Therapeutics$45.11+4.1%3 of 5 stars3.00$68.83 52.6%6Earnings ReportAnalyst ReportNews Coverage1.04%HALOHalozyme Therapeutics$39.91+0.2%5 of 5 stars2.86$53.29 33.5%7Upcoming EarningsAnalyst ReportGap Up1.03%ABBVAbbVie$163.79+1.9%5 of 5 stars2.77$174.31 6.4%13Earnings ReportAnalyst Revision1.01%IDYAIDEAYA Biosciences$42.18+1.7%3 of 5 stars3.00$46.60 10.5%121.01%KRYSKrystal Biotech$161.10+0.5%4 of 5 stars3.00$171.00 6.1%9Upcoming EarningsGap Up1.01%INSMInsmed$25.55-0.4%4 of 5 stars3.00$44.92 75.8%12Upcoming EarningsNews CoverageGap Up1.01%BBIOBridgeBio Pharma$27.83+0.3%5 of 5 stars2.80$47.82 71.8%10Short Interest ↑News CoverageGap Up0.99%GILDGilead Sciences$64.78-0.8%5 of 5 stars2.39$83.69 29.2%18Analyst ReportShort Interest ↓0.99%IMVTImmunovant$28.86+0.3%3 of 5 stars3.00$48.00 66.3%17Short Interest ↓Positive NewsGap Up0.99%INCYIncyte$53.76+1.3%5 of 5 stars2.47$74.93 39.4%17Analyst ReportAnalyst RevisionNews Coverage0.98%IRWDIronwood Pharmaceuticals$8.12-2.2%4 of 5 stars3.00$19.80 143.8%5Upcoming EarningsAnalyst RevisionNews Coverage0.98%DVAXDynavax Technologies$11.74+0.2%4 of 5 stars2.75$25.00 112.9%4Upcoming Earnings0.98%VCELVericel$47.83-0.1%0 of 5 stars3.00$46.40 -3.0%6Upcoming Earnings0.98%SNDXSyndax Pharmaceuticals$22.05+0.9%3 of 5 stars2.90$34.42 56.1%10Upcoming EarningsNews CoverageGap Up0.96%RAREUltragenyx Pharmaceutical$42.75-1.0%4 of 5 stars2.92$88.00 105.8%12Earnings ReportAnalyst ReportNews CoverageGap Up0.95%TWSTTwist Bioscience$41.21+28.7%2 of 5 stars3.00$41.67 1.1%6Earnings ReportAnalyst ReportNews CoverageGap UpHigh Trading Volume0.95%ALKSAlkermes$24.05+0.8%5 of 5 stars2.50$35.38 47.1%10Earnings ReportAnalyst ReportShort Interest ↓Analyst RevisionNews Coverage0.95%PCVXVaxcyte$65.96+2.2%1 of 5 stars3.00$78.50 19.0%4Gap Up0.93%NUVLNuvalent$70.35-3.0%2 of 5 stars2.90$90.78 29.0%10Upcoming EarningsInsider SellingNews Coverage0.93%TGTXTG Therapeutics$16.19-1.4%4 of 5 stars2.83$29.83 84.3%6Earnings ReportAnalyst ReportOptions VolumeAnalyst RevisionNews CoverageGap Up0.92%FOLDAmicus Therapeutics$10.40-0.3%4 of 5 stars3.00$20.00 92.3%3Upcoming EarningsNews CoverageGap Up0.91%CPRXCatalyst Pharmaceuticals$14.72-2.0%5 of 5 stars3.00$26.43 79.5%5Upcoming Earnings0.91%MDGLMadrigal Pharmaceuticals$229.84+6.4%5 of 5 stars2.73$356.73 55.2%11Upcoming Earnings This page (NYSEARCA:XBI) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe only AI company you should be looking atBehind the MarketsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Biotech ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
